SB
CRL icon

Simmons Bank’s Charles River Laboratories CRL Stock Holding History

Simmons Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,200
Closed -$661K – 336
2024
Q2 		$661K Sell
3,200
-30
-0.9% -$6.8K 0.05% 207
2024
Q1 		$875K Sell
3,230
-50
-2% -$11.9K 0.07% 195
2023
Q4 		$775K Sell
3,280
-260
-7% -$51.1K 0.06% 201
2023
Q3 		$694K Buy
3,540
+120
+4% +$24.6K 0.06% 206
2023
Q2 		$719K Buy
3,420
+59
+2% +$11.7K 0.06% 208
2023
Q1 		$678K Sell
3,361
-44
-1% -$9.97K 0.06% 212
2022
Q4 		$742K Sell
3,405
-77
-2% -$16.8K 0.06% 209
2022
Q3 		$685K Sell
3,482
-248
-7% -$53.5K 0.06% 214
2022
Q2 		$798K Sell
3,730
-1,221
-25% -$298K 0.07% 213
2022
Q1 		$1.41M Buy
4,951
+296
+6% +$91.3K 0.11% 175
2021
Q4 		$1.75M Buy
4,655
+25
+0.5% +$9.71K 0.12% 153
2021
Q3 		$1.91M Hold
4,630
– – 0.14% 145
2021
Q2 		$1.71M Sell
4,630
-40
-0.9% -$13.4K 0.12% 151
2021
Q1 		$1.35M Buy
4,670
+570
+14% +$158K 0.1% 175
2020
Q4 		$1.02M Buy
4,100
+335
+9% +$79.8K 0.08% 193
2020
Q3 		$853K Buy
3,765
+10
+0.3% +$2.08K 0.07% 203
2020
Q2 		$655K Sell
3,755
-170
-4% -$27.1K 0.05% 229
2020
Q1 		$495K Hold
3,925
– – 0.04% 243
2019
Q4 		$600K Hold
3,925
– – 0.05% 240
2019
Q3 		$520K Sell
3,925
-100
-2% -$13.4K 0.05% 253
2019
Q2 		$571K Buy
+4,025
New +$546K 0.06% 249

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Simmons Bank's CRL Position: Q3 2024 in Review

Simmons Bank sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 3,200 shares — an estimated $661K sold.

Simmons Bank first reported a position in CRL in Q2 2019 and held it in 21 quarters. The position peaked at $1.91M in Q3 2021. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • Simmons Bank reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • Simmons Bank sold 3,200 Charles River Laboratories shares in Q3 2024, an estimated $661K.
  • Simmons Bank first reported a position in Charles River Laboratories in Q2 2019 and held it in 21 quarters.
  • Simmons Bank's Charles River Laboratories position peaked at $1.91M in Q3 2021.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Simmons Bank's 13F filing for Q3 2024, filed 5 Nov 2024.